DANIELLE TOAL: Open Payments
NPI 1346781069 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,034 in 123 payments from 18 companies in 2025. Trend: 2023 $3,124 · 2024 $3,230 · 2025 $3,034
Food & beverage: $2,934Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $532 |
| ABBVIE INC. | 26 | $530 |
| UCB, Inc. | 10 | $397 |
| Novartis Pharmaceuticals Corporation | 11 | $279 |
| Regeneron Healthcare Solutions, Inc. | 4 | $245 |
| LEO Pharma Inc. | 8 | $181 |
| GENZYME CORPORATION | 7 | $173 |
| Lilly USA, LLC | 7 | $150 |
| Amgen Inc. | 4 | $95 |
| Botanix SB Inc | 5 | $90 |
Products named: TREMFYA, Bimzelx, DUPIXENT, RINVOQ, SKYRIZI, TALTZ, ADBRY, COSENTYX.
Industry payments across MO — which companies pay providers there.
